| Pistachios and Neural Macular Pigment (NCT05283941) | Tufts University | 2022-06-10 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION (NCT05147701) | The Foundation for Orthopaedics and Regenerative Medicine | 2022-02-01 |
| Quest to Analyze One Thousand Humans Meditating (NCT06583395) | Tobias Moeller-Bertram | 2021-12-05 |
| High Resolution Optical Coherence Tomography (NCT05130385) | Insel Gruppe AG, University Hospital Bern | 2021-11-30 |
| Fundus Image-guided Focal Electroretinography, Usability Study (NCT05100511) | Maculaser Oy | 2021-11-04 |
| Visual Telerehabilitation in AMD Patients (NCT04685824) | Michael Reber | 2021-09-15 |
| Study of New Mutations in Cone Disorders (NCT04658251) | University Hospital, Lille | 2021-03-03 |
| Learning Study: Improving Vision in Adults With Macular Degeneration (NCT04762368) | University of Waterloo | 2021-02-13 |
| A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Neovascular Age-related Macular Degeneration (NCT04684394) | Gemini Therapeutics, Inc. | 2020-12-29 |
| Evaluation of the Retinal Health Monitoring System Thickness Module (NCT04499703) | Kubota Vision Inc. | 2020-11-11 |
| Prediction of Progression of Age-Related Macular Degeneration (NCT04640649) | University of Illinois at Chicago | 2020-11-01 |
| Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration (NCT04567303) | Hoffmann-La Roche | 2020-10-28 |
| A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Dry Age-related Macular Degeneration (NCT04643886) | Gemini Therapeutics, Inc. | 2020-07-30 |
| A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) (NCT04435366) | IVERIC bio, Inc. | 2020-06-22 |
| Comparing Vision Tests in a Virtual Reality Headset to Existing Analogues (NCT04714424) | Icahn School of Medicine at Mount Sinai | 2020-01-13 |
| First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration (NCT04246866) | Gemini Therapeutics, Inc. | 2019-12-19 |
| Advancing Understanding of Transportation Options (NCT04141891) | University of Colorado, Denver | 2019-12-12 |
| Improving Vision in Adults With Macular Degeneration (NCT04111068) | University of Waterloo | 2019-12-01 |
| A Study to Test How Well Different Doses of BI 754132 Are Tolerated in Patients With an Advanced Form of Age-related Macular Degeneration Called Geographic Atrophy (NCT04002310) | Boehringer Ingelheim | 2019-07-26 |
| Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD (NCT03954626) | Novartis Pharmaceuticals | 2019-06-07 |
| Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD (NCT03805100) | Xbrane Biopharma AB | 2019-04-19 |
| Long Term Safety of Cooling Anesthesia for Intravitreal Injection (NCT03956797) | Recens Medical, Inc. | 2019-04-15 |
| GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD) (NCT03815825) | Ionis Pharmaceuticals, Inc. | 2019-03-04 |
| Aflibercept Injection Into the Vitreous Body of the Eye: Study to Learn More About Patient Relevant Outcomes, Real World Treatment Patterns and How Well the Treatment Works for Patients Suffering From Abnormal Growth of New Blood Vessels Under the Retina. (NCT03714308) | Bayer | 2019-01-28 |
| GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD) (NCT03894020) | Gyroscope Therapeutics Limited | 2019-01-08 |
| FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD (NCT03846193) | Gyroscope Therapeutics Limited | 2018-12-17 |
| Cooling Anesthesia for Intravitreal Injection (NCT03732287) | Recens Medical, Inc. | 2018-11-30 |
| BCI and Evaluation of Visual and Task Performance in Subjects With Eye Diseases (NCT03318549) | University of Miami | 2018-10-29 |
| Effect of Vitrectomy on the Evolution of Refractory Diabetic Macular Edema (NCT03603990) | Fondation Ophtalmologique Adolphe de Rothschild | 2018-09-01 |
| The Effect of Duration Between Sessions on Microperimetric Biofeedback Training in Patients With Maculopathies (NCT05904444) | Aier Eye Hospital, Guangzhou | 2018-08-15 |
| A Study to Evaluate Abicipar Pegol for Safety and Treatment Effect in Participants With Neovascular Age-related Macular Degeneration (AMD) (NCT03539549) | Allergan | 2018-05-25 |
| An Integrated Analysis of the Effectiveness of Intravitreal (IVT) Aflibercept (Eylea) in Routine Clinical Practice Based on Two Large Observational Studies (NCT03521895) | Bayer | 2018-05-01 |
| Efficacy and Safety Study of CNTO 2476 in Participants With Visual Acuity Impairment Associated With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD) (NCT02895815) | Janssen Pharmaceutical K.K. | 2018-04-09 |
| A Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin America (NCT03470103) | Bayer | 2018-03-28 |
| Evaluate the Effectiveness of Intravitreal (IVT) Aflibercept Injection in Clinical Practice in naïve Patients With Neovascular Age-related Macular Degeneration (nAMD) (NCT03411941) | Bayer | 2018-02-28 |
| "Night Vision and Carotenoids" (NCT04741763) | Robert Davis | 2018-02-13 |
| Evaluation of a New Eye-specific Multivitamin Formula in Participants at Risk of Age-related Macular Degeneration (AMD) (NCT03946085) | Guardion Health Sciences, Inc. | 2018-01-19 |
| Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Japanese Patients With Neovascular AMD (NCT03335852) | Allergan | 2017-11-28 |
| Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging (NCT03105609) | Center for Eye Research Australia | 2017-11-14 |
| Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography (NCT06074731) | Johannes Kepler University of Linz | 2017-06-01 |
| Effect Aflibercept on Ocular Perfusion (NCT03804099) | Augenabteilung Allgemeines Krankenhaus Linz | 2017-03-01 |
| Correlation Between Visual Acuity Measurements, Quality of Life and Morphological Parameters in Wet AMD Patients (NCT03438669) | Dr. med. Katja Hatz | 2017-02-24 |
| Deficits, Adaptation and Cerebral Functional Reorganization of Visual Retinotopic Treatments During Normal and Pathological Aging (Age-related Macular Degeneration and Glaucoma) (NCT03133117) | University Hospital, Grenoble | 2017-02-02 |
| Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Patients With Neovascular AMD (NCT02859766) | Allergan | 2016-12-07 |
| Non-Damaging Photothermal Therapy of Non-exudative Age Related Macular Degeneration (NCT02569892) | Stanford University | 2016-09-01 |
| Ocular Imaging Study Using Advanced OCT (NCT02827071) | University of California, Los Angeles | 2016-07-01 |
| Prospective Observational Study to Assess Effectiveness of Intravitreal Aflibercept in Patients With Wet Macular Degeneration in Greece (NCT02821247) | Bayer | 2016-07-01 |
| Ocular Discomfort Assessment After Intravitreal Injections (NCT02806830) | Centre Hospitalier Intercommunal Creteil | 2016-04-01 |
| Technology-based Eye Care Services (TECS) Compare (NCT02558712) | Emory University | 2016-03-01 |
| Treatment of Age-related Macular Degeneration by Fetal Retinal Pigment Epithelial Cells Transplantation (NCT02868424) | The First Affiliated Hospital with Nanjing Medical University | 2016-02-13 |
| Stem Cell Ophthalmology Treatment Study II (NCT03011541) | MD Stem Cells | 2016-01-01 |
| Evaluation of Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept (NCT02615496) | Bayer | 2015-12-07 |
| A Study to Evaluate the Safety and Clinical Response of Subretinal Administration of CNTO 2476 in Participants With Geographic Atrophy (NCT02659098) | Janssen Research & Development, LLC | 2015-12-04 |
| Managing Neovascular (Known as "Wet") Age-related Macular Degeneration Over 2 Years Using Different Treatment Schedules of 2 mg Intravitreal Aflibercept Injected in the Eye (NCT02581891) | Bayer | 2015-11-19 |
| Assessment of Scan Quality of Sparse OCT Retina Scanner (MimoStudy01) (NCT02555995) | University of Bern | 2015-11-01 |
| Efficacy and Safety of Two Different Aflibercept Regimens in Subjects With Neovascular Age-related Macular Degeneration (nAMD) (NCT02540954) | Bayer | 2015-09-29 |
| Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular Degeneration (NCT02510794) | Genentech, Inc. | 2015-09-28 |
| Analysis of Aqueous and Vitreous Humor (NCT02067013) | California Retina Consultants | 2015-07-01 |
| MP3 (Microperimeter 3) Reproducibility in Healthy Subjects and Macular Patients (NCT02941406) | Vienna Institute for Research in Ocular Surgery | 2015-07-01 |
| Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD (NCT02543229) | Opthea Limited | 2015-07-01 |
| Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration (NCT02462486) | Allergan | 2015-06-25 |
| A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration (NCT02462928) | Allergan | 2015-06-25 |
| Photodynamic Therapy for PDA in NV AMD (NCT02452840) | Duke University | 2015-05-11 |
| Study to Evaluate Home Vision Testing in Participants Who Receive Ranibizumab (Lucentis®) (NCT02420132) | Hoffmann-La Roche | 2015-04-20 |
| X-82 to Treat Age-related Macular Degeneration (NCT02348359) | Tyrogenex | 2015-03-16 |
| Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection (NCT02486484) | Rafic Hariri University Hospital | 2015-03-01 |
| The Focal Electro-Oculogram in Macular Disease (NCT02225119) | National Eye Institute (NEI) | 2015-02-06 |
| Investigating Optical and Neural Causes of Vision Loss (NCT00926913) | US Department of Veterans Affairs | 2014-12-01 |
| Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration (NCT02222207) | Bayer | 2014-10-01 |
| Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD) (NCT02228304) | Neurotech Pharmaceuticals | 2014-09-01 |
| Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study (NCT02390245) | Wills Eye | 2014-09-01 |
| Treatment -Resistant Neovascular Age-Related Macular Degeneration (NCT02332941) | Washington University School of Medicine | 2014-08-01 |
| A Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration (NCT02181517) | Allergan | 2014-07-01 |
| Development of a Device to Measure Dark Adaptation (NCT02090751) | University of Manchester | 2014-07-01 |
| Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment Phase (NCT02032173) | Novartis Pharmaceuticals | 2014-05-19 |
| A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration (NCT02087085) | Allergan | 2014-05-09 |
| Eylea Post Marketing Surveillance(PMS) (NCT01783925) | Bayer | 2014-04-29 |
| EAGLE: Evaluating Genotypes Using Intravitreal Aflibercept Injection (NCT02689518) | University of California, San Diego | 2014-04-01 |
| A Study Testing if Medicine Can Make Pigment Epithelium Detachments Regress and Stabilize the Vision in Eyes (NCT01746875) | Norwegian University of Science and Technology | 2014-02-01 |
| A Study of RO6867461 Administered in Single- and Multiple-Ascending Doses in Patients With Wet Age-Related Macular Degeneration (NCT01941082) | Hoffmann-La Roche | 2013-12-01 |
| Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration (NCT02157077) | Centre Hospitalier Intercommunal Creteil | 2013-12-01 |
| Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy (NCT01771081) | Bayer | 2013-04-01 |
| Drusen Morphology Changes in Nonexudative Age-related Degeneration After Oral Antioxidants Supplementation (NCT02264938) | Germans Trias i Pujol Hospital | 2013-01-01 |
| EYLEA [AMD-QOL(Age-Related Macular Degeneration-Quality of Life)] Post-marketing Surveillance in Japan (NCT01756261) | Bayer | 2012-12-26 |
| EYLEA Age-Related Macular Degeneration (AMD) Post-marketing Surveillance in Japan (NCT01756248) | Bayer | 2012-12-26 |
| Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab (NCT01748292) | Charles C Wykoff, PhD, MD | 2012-12-01 |
| Stem Cell Ophthalmology Treatment Study (NCT01920867) | MD Stem Cells | 2012-08-01 |
| Study to Assess the EffectiVeness of exIsting Anti-vascular Endothelial groWth Factor (Anti-VEGF) Treatment Regimens in Patients With Wet Age-related Macular Degeneration (NCT01933152) | Bayer | 2012-08-01 |
| Effect of Omega-3-fatty Acids on Blood Levels Omega-3 Fatty Acids in Patients With Age-related Macular Degeneration (NCT01653184) | Wills Eye | 2012-07-01 |
| Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD) (NCT01632527) | StemCells, Inc. | 2012-06-01 |
| Analysis of Biomarkers From Patients With Chorioretinal Diseases (NCT02026843) | Kyungpook National University Hospital | 2012-04-01 |
| A Safety And Efficacy Study Of ALG-1001 In Human Subjects With Wet Age-Related Macular Degeneration (NCT01749891) | Allegro Ophthalmics, LLC | 2012-03-01 |
| Biological Sample Collection for Research and Biobanking (NCT04270604) | New York Stem Cell Foundation Research Institute | 2012-02-06 |
| The Impact of Ocular Diseases on Driving: a Prospective Study (NCT02313259) | CHU de Quebec-Universite Laval | 2012-02-01 |
| 12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD) (NCT01362348) | GlaxoSmithKline | 2011-07-07 |
| Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV) (NCT01339949) | Oraya Therapeutics, Inc. | 2011-06-01 |
| Complement Factor H Haplotypes and Smoking in Age-related Macular Degeneration (NCT01115231) | VA Office of Research and Development | 2010-10-01 |
| A Single-Center Pilot Study to Assess Macular Function (NCT01204541) | ORA, Inc. | 2010-09-01 |
| A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration (NCT01154062) | GlaxoSmithKline | 2010-08-16 |
| HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration (NCT01189019) | Anne Fung MD | 2010-08-01 |